You are here

Article Text

Article menu
Download PDFPDF
Papers
New steroids and new salicylates in inflammatory bowel disease: a critical appraisal
  1. M Campieri
  1. Correspondence to:
    Prof M Campieri, Centre for Inflammatory Bowel Disease, Department of Internal Medicine, University of Bologna, 940138 Bologna, Italy;
    campieri{at}med.unibo.it

Abstract

Although new salicylates are now available for the treatment of ulcerative colitis, sulphasazaline still has an important therapeutic role. The role of salicylates in Crohn's disease is limited to the mild activity phase; further data are required to clarify its role in maintenance on remission. New steroids are a real alternative to traditional steroids in active ulcerative colitis and Crohn's disease.

  • steroid
  • salicylate
  • inflammatory bowel disease
  • 5-ASA, 5-aminosalicylic acid
  • BDP, beclomethasone diproprionate
  • CD, Crohn's disease
  • CIR, controlled ileal release
  • GCS, glucocorticosteroid
  • IBD, inflammatory bowel disease
  • SP, sulphapyridine
  • SSP, sulphasalazine
  • UC, ulcerative colitis

https://doi.org/10.1136/gut.50.suppl_3.iii43

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text